Aquilani, R.; Brugnatelli, S.; Maestri, R.; Boschi, F.; Filippi, B.; Perrone, L.; Barbieri, A.; Buonocore, D.; Dossena, M.; Verri, M.
Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State. Curr. Oncol. 2021, 28, 3280-3296.
https://doi.org/10.3390/curroncol28050285
AMA Style
Aquilani R, Brugnatelli S, Maestri R, Boschi F, Filippi B, Perrone L, Barbieri A, Buonocore D, Dossena M, Verri M.
Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State. Current Oncology. 2021; 28(5):3280-3296.
https://doi.org/10.3390/curroncol28050285
Chicago/Turabian Style
Aquilani, Roberto, Silvia Brugnatelli, Roberto Maestri, Federica Boschi, Beatrice Filippi, Lorenzo Perrone, Annalisa Barbieri, Daniela Buonocore, Maurizia Dossena, and Manuela Verri.
2021. "Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State" Current Oncology 28, no. 5: 3280-3296.
https://doi.org/10.3390/curroncol28050285
APA Style
Aquilani, R., Brugnatelli, S., Maestri, R., Boschi, F., Filippi, B., Perrone, L., Barbieri, A., Buonocore, D., Dossena, M., & Verri, M.
(2021). Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State. Current Oncology, 28(5), 3280-3296.
https://doi.org/10.3390/curroncol28050285